Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Trigger Point Pain, Myofascial: early-phase trial registry
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Trigger Point Pain, Myofascial: 3 US clinical trials tracked, none currently recruiting.
Trigger Point Pain, Myofascial is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is David Grant U.S. Air Force Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition trigger-point-pain-myofascial
OPEN 0 | RECR 0% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Trigger Point Pain, Myofascial has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Trigger Point Pain, Myofascial on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Trigger Point Pain, Myofascial is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Evaluation of a Novel Class of Objective Myofascial Pain Assessments
Beth Israel Deaconess Medical Center
NCT05793086
Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty
David Grant U.S. Air Force Medical Center
NCT06955923
Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain
University Hospitals Cleveland Medical Center
NCT02173405
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Trigger Point Pain, Myofascial records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Trigger Point Pain, Myofascial trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Trigger Point Pain, Myofascial page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Trigger Point Pain, Myofascial trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- David Grant U.S. Air Force Medical Center sponsors the most Trigger Point Pain, Myofascial trials on record, review their full trial history before evaluating a specific study. See David Grant U.S. Air Force Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Trigger Point Pain, Myofascial condition card totals 3 registered trials; most-linked intervention Trigger point injection (lidocaine); top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.